上海大学学报(自然科学版) ›› 2016, Vol. 22 ›› Issue (3): 285-292.doi: 10.3969/j.issn.1007-2861.2016.04.001

• 心脏重构与再生专刊 • 上一篇    下一篇

诱导多能干细胞与心脏再生

胡士军1,2, 虞游1,2, 方星1,2, 雷伟1,2, 赵振奥1,2   

  1. 1. 苏州大学心血管病研究所, 江苏苏州215000;
    2. 苏州大学附属第一医院心血管外科, 江苏苏州215006
  • 收稿日期:2016-04-22 出版日期:2016-06-30 发布日期:2016-06-30
  • 通讯作者: 胡士军(1980—), 男, 教授, 博士生导师, 研究方向为干细胞与心血管转化医学. E-mail: shijunhu@suda.edu.cn
  • 作者简介:胡士军(1980—), 男, 教授, 博士生导师, 研究方向为干细胞与心血管转化医学. E-mail: shijunhu@suda.edu.cn
  • 基金资助:

    国家自然科学基金资助项目(81500277)

Induced pluripotent stem cells in cardiac regeneration

HU Shijun1,2, YU You1,2, FANG Xing1,2, LEI Wei1,2, ZHAO Zhen’ao1,2   

  1. 1. Institute for Cardiovascular Science, Soochow University, Suzhou 215000, Jiangsu, China;
    2. Department of Cardiovascular Surgery, First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu, China
  • Received:2016-04-22 Online:2016-06-30 Published:2016-06-30

摘要:

诱导多能干细胞(induced pluripotent stem cells, iPSCs)研究的快速发展为心血管转化医学研究领域提供了新的策略. 诱导多能干细胞不仅具有与胚胎干细胞类似的多能性, 且巧妙地回避了胚胎干细胞面临的伦理学问题和免疫排斥反应. 心肌细胞等成体心血管细胞在发生心血管疾病后增殖能力有限, 而iPSCs 来源的心血管细胞在心脏再生治疗中颇具应用前景,是理想的细胞来源, 因此在基础医学和转化医学研究领域受到广泛关注. 就iPSCs 的发展过程及其在心脏再生中的应用作一综述, 并探讨目前iPSCs 在心脏再生临床转化中亟待解决的问题.

关键词:  ,  ,  , 心脏再生 , 诱导多能干细胞 , 重编程, 转化医学

Abstract:

Induced pluripotent stem cells (iPSCs) have emerged as a novel tool for cell therapy for cardiovascular diseases. iPSCs are functionally similar to embryonic stem cells (ESCs) while avoiding ethical issues and immune rejection. Given limited regenerative ability of human heart following cardiovascular diseases cardiovascular cells derived from iPSCs have been considered as a promising cell source in cardiovascular regenerative therapy. This paper summarizes and discusses the iPSCs technology and its potential regenerative applications in cardiac regeneration.

Key words:  cardiac regeneration ,  reprogramming,  translational medicine , induced pluripotent stem cell (iPSCs)